![](/img/cover-not-exists.png)
Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma
Beca, Jaclyn M., Raza, Kaiwan, Mow, Elena, Keech, James, Kouroukis, C. TomLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1711902
Date:
January, 2020
File:
PDF, 1.70 MB
english, 2020